EUS-guided gastroenterostomy vs. surgical gastrojejunostomy and enteral stenting for malignant gastric outlet obstruction: a meta-analysis
Endoscopy International Open · 2023-07 · 11 (07) · E660-E672
DOI: 10.1055/a-2098-2570 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endoscopy International Open, online erschienen am 26.07.2023. Verfasst von Corey Miller und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Medicine, Jewish General Hospital, Montreal, Canada. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and study aims Malignant gastric outlet obstruction (MGOO) is traditionally treated with surgical gastrojejunostomy (SGJ), which is effective but associated with high rates of morbidity, or endoscopic stenting (ES), which is less invasive but associated with significant risk of stent dysfunction and need for reintervention. Endoscopic ultrasound-guided gastroenterostomy (EUS-GE) provides a robust bypass without the invasiveness of surgery.
Methods
We performed a systematic review and meta-analysis comparing EUS-GE to SGJ and ES for MGOO. Electronic databases were searched from inception through February 2022. A meta-analysis was performed with results reported as odds ratios (ORs) with 95% confidence intervals (CIs) using random effects models. Primary outcomes included clinical success without recurrent GOO and adverse events (AEs).
Results
Sixteen studies involving 1541 patients were included. EUS-GE was associated with higher clinical success without recurrent GOO compared to ES or SGJ [OR 2.60, 95% CI1.58–4.28] and compared to ES alone [OR 5.08, 95% CI 3.42–7.55], but yielded no significant difference compared to SGJ alone [OR 1.94, 95% CI 0.97–3.88]. AE rates were significantly lower for EUS-GE compared to ES or SGJ grouped together [OR 0.34, 95% CI 0.20–0.58], or SGJ alone [OR 0.17, 95% CI 0.10–0.30] but were not significant different versus ES alone [OR 0.57, 95% CI 0.29–1.14].
Conclusions
EUS-GE is the most successful approach to treating MGOO, exhibiting a lower risk of recurrent obstruction compared to ES, and fewer AEs compared to SGJ.
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Medicine, Jewish General Hospital, Montreal, Canada.
- Division of Experimental Medicine, Department of Medicine, McGill University Faculty of Medicine and Health Sciences, Montreal, Canada.
- Faculty of Medicine, McGill University, Montreal, Canada.
- Research Institute of the McGill University Health Center, McGill University Health Centre, Montreal, Canada.
- Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Canada.
- Surgery, McGill University Health Centre, Montreal, Canada.
Zitieren
APA
Miller, C., Benchaya, J. A., Martel, M., Barkun, A., Wyse, J. M., Ferri, L., & Chen, Y. I. (2023). EUS-guided gastroenterostomy vs. surgical gastrojejunostomy and enteral stenting for malignant gastric outlet obstruction: a meta-analysis. Endoscopy International Open, 11(07), E660-E672. https://doi.org/10.1055/a-2098-2570
Vancouver
Miller C, Benchaya JA, Martel M, Barkun A, Wyse JM, Ferri L, et al. EUS-guided gastroenterostomy vs. surgical gastrojejunostomy and enteral stenting for malignant gastric outlet obstruction: a meta-analysis. Endoscopy International Open. 2023;11(07):E660-E672. doi:10.1055/a-2098-2570
BibTeX
@article{Miller2023,
author = {Miller, Corey and Benchaya, Joshua A and Martel, Myriam and Barkun, Alan and Wyse, Jonathan M and Ferri, Lorenzo and Chen, Yen-I},
title = {EUS-guided gastroenterostomy vs. surgical gastrojejunostomy and enteral stenting for malignant gastric outlet obstruction: a meta-analysis},
journal = {Endoscopy International Open},
year = {2023},
volume = {11},
number = {07},
pages = {E660--E672},
doi = {10.1055/a-2098-2570}
}
EUVIMED